News · 26 weeks60-38%
2026-03-012026-08-23
Mix2790d
- Insider8(30%)
- Other6(22%)
- SEC Filings5(19%)
- Analyst3(11%)
- Earnings3(11%)
- Leadership2(7%)
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by Inspire Medical Systems Inc.SCHEDULE 13G - Inspire Medical Systems, Inc. (0001609550) (Subject)
- INSIDEROfficer Kelly Jason P sold $57,347 worth of shares (963 units at $59.55), decreasing direct ownership by 5% to 18,985 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERChief People Officer Mann Melissa covered exercise/tax liability with 652 shares, decreasing direct ownership by 3% to 22,957 units (SEC Form 4) to satisfy withholding tax4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- ANALYSTInspire Medical Systems upgraded by Oppenheimer with a new price targetOppenheimer upgraded Inspire Medical Systems from Perform to Outperform and set a new price target of $85.00
- SECSEC Form 10-Q filed by Inspire Medical Systems Inc.10-Q - Inspire Medical Systems, Inc. (0001609550) (Filer)
- PRMobia Medical Appoints Myriam Curet, M.D., to its Board of DirectorsAUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (NASDAQ:MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Myriam Curet, M.D., to the Board as an independent director, effective July 30, 2026. "We are thrilled Myriam will be joining the Mobia Medical Board of Directors," said Richard Foust, President and Chief Executive Officer of Mobia Medical. "Her decades long clinical and executive leadership at Intuitive Surgical paired with her ongoing surgical practice and public company board experience bring a unique combination of medical and corporate gove
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- PRInspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth PlanGenerated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan designed to unlock and redeploy $30 million for growth initiatives MINNEAPOLIS, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended June 30, 2026. "Our second quarter results reflect the increased discipline and focus we are b
- ANALYSTUBS resumed coverage on Inspire Medical Systems with a new price targetUBS resumed coverage of Inspire Medical Systems with a rating of Sell and set a new price target of $39.00
- INSIDERDirector Carrel Michael H was granted 5,631 shares (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERSEC Form 3 filed by new insider Carrel Michael H3 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- PRInspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of DirectorsMINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the appointment of seasoned medical device executive Michael H. Carrel to its Board of Directors effective July 20. "We are pleased to welcome Mr. Carrel to our Board of Directors," said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. "Mike brings extensive executive leadership, board and medical device experience, including a strong track record of developing and commercializing minimally invasive therapies, and we look forwar
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- PRInspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of DirectorsMINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the retirement of Casey M. Tansey from the Inspire Board after more than eighteen years of service, effective July 30. "We are thankful for the many contributions Mr. Tansey has made to our Board of Directors over the past eighteen years," said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. "As one of the first venture investors to recognize the potential impact of Inspire therapy for patients with OSA, Mr. Tansey has provided
- INSIDERDirector Melenikiotou Georgia was granted 344 shares, increasing direct ownership by 4% to 8,329 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Tansey Casey M was granted 346 shares, increasing direct ownership by 1% to 26,632 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Ellis Gary Lee was granted 581 shares, increasing direct ownership by 5% to 11,419 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- INSIDERDirector Broader Shelley G was granted 383 shares, increasing direct ownership by 5% to 8,854 units (SEC Form 4)4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)
- PRCorrection: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed. Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not pl
- PRInspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the followin
- SECSEC Form SCHEDULE 13G filed by Inspire Medical Systems Inc.SCHEDULE 13G - Inspire Medical Systems, Inc. (0001609550) (Subject)
- SECInspire Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)
- ANALYSTInspire Medical Systems downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Inspire Medical Systems from Outperform to In-line and set a new price target of $40.00
- PRInspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR StudyMINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced its participation in SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 14–17 in Baltimore, Maryland. SLEEP is the premier global forum for sleep medicine and research, jointly hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS). Advancing Innovation and Clinical Evidence "We are pleased to return to SLEEP and showcase the continued evolution of the Inspire
INSP FAQ
7 questionsWhat does Inspire Medical Systems Inc. do?
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is...Where does INSP stock trade?
Inspire Medical Systems Inc. (INSP) is listed on NYSE.What sector and industry is INSP in?
Inspire Medical Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Inspire Medical Systems Inc. go public?
Inspire Medical Systems Inc. (INSP) completed its IPO in 2018.What are analysts saying about INSP?
Inspire Medical Systems Inc. has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Outperform on 2026-08-04. Recent price targets range from $3900.00 to $4000.00.What companies are similar to INSP?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare INSP side-by-side with any of them on Quantisnow.How can I track INSP on Quantisnow?
Quantisnow aggregates Inspire Medical Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow INSP to receive live email and push alerts on every new disclosure.